NCT06182995 · ACTIVE NOT RECRUITING

Anticipating Decline and Providing Therapy

This trial tests a post-ICU support program called ADAPT against usual care for older adults who experienced delirium during a serious illness. The goal is to see whether early screening and structured follow-up can reduce cognitive decline after an ICU stay. This is a Phase NA pilot feasibility study, meaning researchers are checking whether the approach is practical and worth testing at larger scale — it is not yet proven or approved.

You may qualify if

  • Age 60 and older at time of discharge from intensive care unit
  • Minimum 72 hour Intensive Care Unit stay in an ICU at Atrium Health Wake Forest Baptist
  • Delirium during ICU stay as determined by positive Confusion Assessment Method (CAM)-ICU score, review of clinical - documentation, or discussion with clinical team
  • Primary care provider in the Atrium Health Wake Forest system or intention to follow with Primary Care Physician in Atrium Health system
  • English speaking

You're excluded if

  • Death during initial hospitalization and/or discharge to Hospice
  • Life-expectancy \< 6 months from pre-existing illness (defined as diagnosis of metastatic cancer, cirrhosis, advanced heart failure, prior palliative care referral)
  • Acute Traumatic Brain Injury
  • Continued residence in skilled nursing facility or rehab that prevents ability to complete study telephone call at time of first cognitive screen attempt
  • Prior history of dementia in electronic health record
  • Language or communication barrier that prohibits intervention participation
  • Participant cannot identify family or caregiver contact or family/caregiver unwilling to participate
  • Subject or legally authorized representative (LAR) decline consent
  • Unstable telephone service for contact after hospital discharge
  • Primary residence outside of North Carolina

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-07-24

View full record on ClinicalTrials.gov

All APOE4 clinical trials